VERCISE GEVIA
Report
- Report Number
- 3006630150-2023-07193
- Event Type
- Injury
- Date Received
- November 20, 2023
- Date of Event
- October 26, 2023
- Report Date
- December 14, 2023
- Manufacturer
- BOSTON SCIENTIFIC NEUROMODULATION
- Product Code
- MHY
- PMA / PMN Number
- P150031
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CO
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION, UPN: M365NM3138550, MODEL: NM-3138-55, SERIAL: (B)(6), BATCH: (B)(6). PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(6), BATCH: (B)(6).
ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365NM3138550. MODEL: NM-3138-55. SERIAL: (B)(6). BATCH: 7101056. PRODUCT FAMILY: DBS-LINEAR LEADS. UPN: M365DB2202450. MODEL: DB-2202-45. SERIAL: (B)(6). BATCH: 7093057.
ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION UPN: M365NM3138550. MODEL: NM-3138-55. SERIAL: (B)(6). BATCH: 7101056. PRODUCT FAMILY: DBS-LINEAR LEADS UPN: M365DB2202450. MODEL: DB-2202-45. SERIAL: (B)(6). BATCH: 7093057.
IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT EXPERIENCED INFLAMMATION AND EDEMA. THE PHYSICIAN NOTED EXPOSURE OF THE LEAD AND LEAD EXTENSION CONNECTION. THE PATIENT UNDERWENT A WOUND WASHOUT, DEBRIDEMENT AND RELOCATION OF THE IMPLANTABLE PULSE GENERATOR (IPG). THE PATIENT WAS ALSO ADMINISTERED ANTIBIOTICS. ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE PATIENT WAS ADMINISTERED CLINDAMYCIN AND WAS DOING WELL.
IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT EXPERIENCED INFLAMMATION AND EDEMA. THE PHYSICIAN NOTED EXPOSURE OF THE LEAD AND LEAD EXTENSION CONNECTION. THE PATIENT UNDERWENT A WOUND WASHOUT, DEBRIDEMENT AND RELOCATION OF THE IMPLANTABLE PULSE GENERATOR (IPG). THE PATIENT WAS ALSO ADMINISTERED ANTIBIOTICS. ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE PATIENT WAS ADMINISTERED CLINDAMYCIN AND WAS DOING WELL. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT UNDERWENT AN ADDITIONAL WOUND WASH AS THE EXTENSION WAS RE-EXPOSED.
IT WAS REPORTED THAT THE DEEP BRAIN STIMULATION (DBS) PATIENT EXPERIENCED INFLAMMATION AND EDEMA. THE PHYSICIAN NOTED EXPOSURE OF THE LEAD AND LEAD EXTENSION CONNECTION. THE PATIENT UNDERWENT A WOUND WASHOUT, DEBRIDEMENT AND RELOCATION OF THE IMPLANTABLE PULSE GENERATOR (IPG). THE PATIENT WAS ALSO ADMINISTERED ANTIBIOTICS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1719819 | VERCISE GEVIA | STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR | MHY | BOSTON SCIENTIFIC NEUROMODULATION | DB-1200 | 748157 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Male | Required Intervention |